US Patent 10098968 Anti-EGFR antibodies and antibody drug conjugates
Patent 10098968 was granted and assigned to AbbVie Inc. on October, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10098968 Anti-EGFR antibodies and antibody drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
